Connor, Clark & Lunn Investment Management Ltd. Novo Cure LTD Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Novo Cure LTD stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 534,749 shares of NVCR stock, worth $9.04 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
534,749
Previous 437,772
22.15%
Holding current value
$9.04 Million
Previous $13 Million
26.95%
% of portfolio
0.05%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$205 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$190 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$151 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$93.3 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$88.1 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.77B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...